Iovance Biotherapeutics Medical Monitor
Iovance Biotherapeutics, Inc. · Iovance Biotherapeutics
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Iovance Biotherapeutics Medical Monitor as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:24 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04155710 · Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLLIovance Biotherapeutics, Inc. · completed · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma · study chair
- Ph2NCT03645928 · Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid TumorsIovance Biotherapeutics, Inc. · terminated · Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, Non-small Cell Lung Cancer · study director
- Ph2NCT03083873 · Study of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & NeckIovance Biotherapeutics, Inc. · completed · Squamous Cell Carcinoma of the Head and Neck · study director
- Ph2NCT02360579 · Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic MelanomaIovance Biotherapeutics, Inc. · completed · Metastatic Melanoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.